Literatur
Descargues P, Deraison C, Prost C et al (2006) Corneodesmosomal cadherins are preferential targets of stratum corneum trypsin- and chymotrypsin-like hyperactivityin Netherton syndrome. J Invest Dermatol 126:1622–1632
Fontao L, Laffitte E, Briot A et al (2011) Infliximab infusions for Netherton syndrome: sustained clinical improvement correlates with a reduction of thymic stromal lymphopoietin levels in the skin. J Invest Dermatol 131:1947–1950
Hachem JP, Wagberg F, Schmuth M et al (2006) Serine protease activity and residual LEKTI expression determine phenotype in Netherton syndrome. J Invest Dermatol 126:1609–1621
Komatsu N, Saijoh K, Jayakumar A et al (2008) Correlation between SPINK5 gene mutations and clinical manifestations in Netherton Syndrome patients. J Invest Dermatol 128:1148–1159
Saif GB, Al-Khenaizan S (2007) Netherton syndrome: successful use of topical tacrolimus and pimecrolimus in four siblings. Int J Dermatol 46:290–294
Interessenkonflikt
Der korrespondierende Autor gibt für sich und seine Koautoren an, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hammer, C., Voshege, N., Hillen, U. et al. Generalisiertes Erythem, Schuppung und Haaranomalie. Hautarzt 64, 516–518 (2013). https://doi.org/10.1007/s00105-013-2582-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00105-013-2582-5